CCCI yields 20000000.00% · PFE yields 6.13%● Live data
📍 CCCI pulled ahead of the other in Year 1
Combined, CCCI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CCCI + PFE for your $10,000?
China Cable and Communication, Inc. operates as a cable television company in the People's Republic of China (PRC). It owns 49% interest in Baoding Pascali Broadcasting Cable Television Integrated Information Networking Co., Ltd. (joint venture), which operates a cable television network in the municipality of Baoding in PRC. As of December 31, 2004, the joint venture offered 39 channels within the city limits and 8 channels to outer areas in the Baoding metropolitan area. It transmits in both analog and digital over its fiber optic network, as well as through 22 substations IP broadband local area network, 1,310 analog backbone ring networks linking up the city, and 5 base transceiver stations. In addition, the company provides Internet access and value added services, such as broadband Internet access and on-demand services through its set-top boxes. China Cable and Communication is based in Beijing, the People's Republic of China.
Full CCCI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.